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We evaluated the genetic diversity of Streptococcus suis isolates of different serotypes by macrorestriction
analysis and elucidated possible relationships between the genetic background, expression of potential viru-
lence traits, and source of isolation. Virulence traits included expression of serotype-specific polysaccharides,
muramidase-released protein (MRP), extracellular protein factor (EF), hemolysin activity, and adherence to
epithelial cells. Macrorestriction analysis of streptococcal DNA digested with restriction enzymes SmaI and
ApaI allowed differentiation of single isolates that could be assigned to four major clusters, named A1, A2, B1,
and B2. Comparison of the genotypic and phenotypic features of the isolates with their source of isolation
showed that (i) the S. suis population examined, which originated mainly from German pigs, exhibited a genetic
diversity and phenotypic patterns comparable to those found for isolates from other European countries; (ii)
certain phenotypic features, such as the presence of capsular antigens of serotypes 2, 1, and 9, expression of
MRP and EF, and hemolysin activity (and in particular, combinations of these features), were strongly
associated with the clinical background of meningitis and septicemia; and (iii) isolates from pigs with
meningitis and septicemia showed a significantly higher degree of genetic homogeneity compared to that for
isolates from pigs with pneumonia and healthy pigs. Since the former isolates are considered highly virulent,
this supports the theory of a clonal relationship among highly virulent strains.
Streptococcus suis is a major cause of meningitis, septicemia,
arthritis, and bronchopneumonia in young pigs and can cause
meningitis in humans (1, 2). Effective control of the disease is
hampered by the poor knowledge about its epidemiology and
pathogenesis. Since many healthy pigs harbor S. suis as an
“early colonizer” (6, 18), identification of virulent S. suis iso-
lates is of particular importance. This is, however, complicated
by the pathogen’s extreme diversity, in particular with respect
to its virulence.
Phenotypic markers used to distinguish highly virulent and
avirulent isolates include the presence of serotype-specific cap-
sular polysaccharides (25), expression of muramidase-relased
protein (MRP) (27, 35) and extracellular protein factor (EF)
(35), and hemolysin activity (10, 11, 16). The role of these
factors as virulence markers, however, is still unclear. The
capsular polysaccharides are the basis for classification into
serotypes (of which 35 are currently known) and have recently
been shown to prevent phagocytosis and, thus, have been pro-
posed as an important virulence trait (25). Serotype 2 is con-
sidered the most dominant one among highly virulent strains,
but disease is also frequently caused by strains of other sero-
types (24, 33, 36), suggesting that serotype-independent viru-
lence markers must exist. MRP and EF have previously been
found to be strongly associated with highly virulent isolates in
Europe (35, 36) but do not appear to confer virulence directly,
as recently demonstrated by the use of gene knockout technol-
ogy (28). Hemolysin activity has been characterized and asso-
ciated with virulent strains, but its in vivo expression does not
seem to correlate with virulence (11, 12, 15). Adherence to
epithelial cells has also been suggested as a virulence trait (9),
and adhesins that recognize erythrocytes have been found to
induce opsonizing antibodies in mice (32). However, studies
with adhesins were limited to a very few strains, and informa-
tion concerning the adherence mechanisms and the possible
role of adhesins in the virulence of the bacterium is yet very
poor.
Different molecular typing methods such as ribotyping have
been evaluated in comparison with conventional phenotyping,
indicating that the latter is of limited value for epidemiological
analyses (12, 21, 23, 25, 29). Results of these studies also
revealed an association between virulence and ribotype, thus
demonstrating that a close relationship between highly virulent
strains is plausible (23, 26, 29). Nevertheless, most of these
studies were restricted to serotype 2 isolates, and the hypoth-
esis about a clonal lineage or relationship of highly virulent
strains is still under debate (4, 12, 13, 19).
The purpose of the present study was to elucidate the ge-
netic diversity within an S. suis population belonging to various
serotypes, particularly by comparing isolates from pigs with
invasive disease, i.e., meningitis and septicemia, versus isolates
from pigs with pneumonia and healthy pigs. For this, we stud-
ied a collection of 99 isolates, mostly recovered from German
pigs, by assessing possible relationships between the genetic
background, different phenotypic markers (serotype, expres-
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sion of MRP and EF, hemolysin activity, adherence to epithe-
lial cells), and clinical backgrounds.
MATERIALS AND METHODS
If not stated otherwise, all chemicals were purchased from Sigma (Munich,
Germany).
Bacteria. S. suis isolates had been randomly collected in the course of routine
diagnostic procedures from tissues of healthy and diseased pigs over a period of
3 years (1996 to 1998). Most pigs were 4 to 12 weeks old and from different farms
located in different geographic regions in (especially northern) Germany. Ac-
cording to the source of isolation and clinical background, the isolates were
assigned to three groups, i.e., (i) those from pigs with meningitis, septicemia, or
arthritis (isolates from brains and joints of animals with respective clinical symp-
toms [also referred to as meningitis-septicemia isolates]), (ii) those from pigs
with pneumonia (S. suis was isolated from lungs, either as a pure culture [40% of
all pneumonia isolates] or in association with other respiratory pathogens such as
Pasteurella spp. and Bordetella bronchiseptica [60% of all pneumonia isolates]),
and (iii) those from healthy pigs (isolated from swabs of the upper respiratory or
the genital tract). For comparison purposes, a number of reference and control
strains were included, such as the suilysin control strain P1/7 described by Jacobs
et al. (15), serotype 2 reference strain Henrichsen S735 (DSM 9682; German
Culture Collection, Braunschweig, Germany), serotype 1 reference strain Hen-
richsen S428 (DSM 9683), and MRP-EF control strains D282, T15, and 4005
(34). Bacteria were isolated on blood agar plates, identified as S. suis by standard
biochemical testing, and cultured in Todd-Hewitt broth (Oxoid, Wesel, Germa-
ny), on blood agar plates, or on tryptic soy agar plates for 18 h at 37°C.
Phenotyping. (i) Serotyping and expression of MRP and EF. Serotyping and
determination of expression of MRP and EF were done as described previously
(33). Serotype-specific antisera had been prepared in rabbits (8) against refer-
ence strains of serotypes 1 to 28.
(ii) Hemolysin activity. Determination of hemolysin activity was done as de-
scribed by Staats et al. (29), with some minor modifications. Briefly, streptococci
from an overnight plate culture on tryptic soy agar were washed and suspended
in phosphate-buffered saline (PBS) to an optical density (OD) at 560 nm of 1.6.
The suspensions were incubated for 1 h at 40°C to optimize hemolysin produc-
tion and centrifuged, and the supernatants were immediately tested for hemo-
lysin activity by using 1% sheep erythrocytes in PBS. Tests were run in round-
bottom 96-well microtiter plates as twofold serial dilutions beginning with 100 ml
of supernatant. A total of 100 ml of erythrocytes was added to each dilution.
After incubation for 2 h at 37°C in 6% CO2, the plates were centrifuged and the
supernatants were transferred to a new plate for spectrophotometric measure-
ments at 410 nm. As controls, streptococcal supernatants were replaced by PBS
(negative control) or H2O (positive control). Each experiment was run in trip-
licate and included a freshly prepared supernatant of hemolysin control strain
P1/7 as an internal reference. Results were expressed as mean relative hemolysin
activity as a percentage of the activity expressed by strain P1/7. According to the
resulting activities, the isolates were grouped as hemolysin negative (,10% of
the hemolysin activity of P1/7), intermediate (10 to 80% of the hemolysin activity
of P1/7), or positive (.80% of the hemolysin activity of P1/7).
(iii) Adherence to epithelial cells. Adherence to epithelial cells was tested as
described previously (31) by using human HEp-2 cells (ATCC CCL23) and a
porcine testis epithelial cell line (kindly supplied by G. Herrler, Institut fuer
Virologie, Tieraerztliche Hochschule Hannover) grown to confluency on glass
coverslips. Approximately 100 streptococci per epithelial cell were incubated for
1 h at 37°C. After three washes with PBS, the coverslips were stained with
Giemsa and examined microscopically by counting the number of adherent
streptococci per 50 epithelial cells. The results were expressed as adherence
negative (,25 adherent bacteria), intermediate (25 to 100 adherent bacteria), or
positive (.100 adherent bacteria).
PFGE. Macrorestriction analysis by pulsed-field gel electrophoresis (PFGE)
was done by using a modification of the method of Olsen and Skov (22). Strep-
tococcal DNA was prepared from 18-h cultures in Todd-Hewitt broth. After
centrifugation of the cultures, the pelleted bacteria were washed and adjusted to
an OD at 576 nm of 0.3 with PFGE buffer (1 M NaCl, 10 mM EDTA, 10 mM
Tris-HCl [pH 8.0]). Five milliliters of this suspension was pelleted, washed once
in PFGE buffer, resuspended in 0.5 ml of PFGE buffer, mixed with 0.5 ml of
low-melting-temperature high-purity agarose (1.2%; Bio-Rad, Munich, Germa-
ny), and subsequently aliquoted into 100-ml portions and placed into a plug mold.
After solidification, five plugs each were placed in 3 ml of fresh lysis buffer (1 M
NaCl, 200 mM EDTA, 10 mM Tris-HCl [pH 8.0], 0.5% sarcosyl, 0.2% sodium
deoyxycholate, 1 mg of lysozyme per ml, 2 mg of RNase per ml, 13 U of
mutanolysin per ml). After incubation for 2 h at 37°C, the lysis solution was
replaced by 3 ml of ESP buffer (0.5 M EDTA, 1% sarcosyl, 1 mg of proteinase
K per ml) and further incubated overnight at 56°C. Subsequently, the plugs were
washed with TE buffer (10 mM Tris-HCl [pH 8.0], 1 mM EDTA) and incubated
twice in TE buffer containing 1 mM phenylmethylsulfonic acid fluoride for 30
min at room temperature. Then the plugs were washed three times for 30 min
each time with 3 ml of TE buffer. After the final washing, 5 ml of TE buffer was
added and the plugs were stored overnight at 4°C. For digestion with the restric-
tion enzymes SmaI and ApaI (Boehringer Mannheim, Mannheim, Germany),
approximately 0.5-mm slices of the plugs were cut and equilibrated in 250 ml of
restriction enzyme reaction buffer (as supplied by the manufacturer). After 1 h of
equilibration at room temperature, the buffer was replaced by 50 ml of freshly
prepared restriction enzyme reaction buffer containing 10 U of SmaI or ApaI per
ml. After incubation for 4 h at 37°C, the resulting DNA fragments were sepa-
rated by PFGE for 14 h (SmaI digestion) or 18 h (ApaI digestion) at 6 V/cm with
a CHEF DR II apparatus (Bio-Rad). Subsequently, the bands were visualized by
staining of the gels with ethidium bromide and documented under UV illumi-
nation with (the MulitAnalyst system (Bio-Rad).
Analysis of PFGE patterns. Fragment sizes were calculated for each lane by
comparison with a size standard (ApaI-digested genomic DNA from Staphylo-
coccus aureus strain DSM 1104 [German Culture Collection]) which was run in
parallel in each experiment. Bands of less than 50 kb were not included to avoid
possible interference of plasmid DNA. On the basis of the calculated sizes of the
resulting DNA fragments, the gels were analyzed with GelCompar software
(Applied Maths, Kortrijr, Belgium, supplied by HeroLab, Wiesloch, Germany).
Dendrograms were generated by using the Dice coefficient, and clustering was
done by the unweighted pair group method with arithmetic averages (UPGMA)
with a 3% tolerance in band size.
Statistical analysis. The statistical significance of probabilities of dependences
between different phenotypes, assignment to PFGE clusters, and clinical back-
grounds was analyzed by linear regression (odds ratio) by the chi-square test. P
values of less than 0.01 were considered significant.
RESULTS
Macrorestriction analysis. Macrorestriction analysis was
done by PFGE of streptococcal DNA digested with restriction
enzymes SmaI and ApaI. The number of bands obtained with
SmaI-digested DNA ranged from 6 to 13, and the number of
bands obtained with ApaI-digested DNA ranged from 15 to 23.
Genome sizes calculated by addition of DNA fragments of
various sizes varied; for most isolates a genome size of 1.4 3
106 to 2.0 3 106 bp was calculated. This corresponded to the
genome size of streptococci as indicated in the literature (30)
(additional details can be found at the genome website Uni-
versity of Oklahoma’s Advanced Center for Genome Technology
(http://www.genome.ou.de/strep.html). Representative PFGE
gels of SmaI-digested DNAs of isolates mainly belonging to
serotype 9 are shown in Fig. 1A, and PFGE gels of ApaI-
digested DNAs of isolates mainly belonging to serotype 2 are
shown in Fig. 1B. The data show that PFGE allowed differen-
tiation of isolates between and within serotypes. Moreover,
PFGE enabled us to monitor isolates from various locations of
a single animal (Fig. 1A, lanes 11 and 12; Fig. 1B, lanes 17 to
19) as well as from different animals within the same herd (Fig.
1A, lanes 10, 16, and 20). Strongly related but not identical
isolates could also easily be discriminated (Fig. 1A, lanes 21
and 22; Fig. 1B, lanes 20 to 24). Cluster analysis of PFGE
patterns of SmaI-digested DNA by UPGMA revealed a den-
drogram with four major groups, designated groups A1, A2,
B1, and B2, each comprising isolates with a similarity of at least
20% (Fig. 2). Isolates which appeared to be identical by visual
inspection of the gels showed similarities of approximately 80
to 100% by cluster analysis. Examples are isolates I9841/1-3
(Fig. 2, cluster A1, corresponding to Fig. 1B, lanes 17 to 19) as
well as isolates A3313/1/98 and A3313/3/98 (Fig. 2, cluster B1,
corresponding to Fig. 1A, lanes 11 and 12). Closely related
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isolates showed similarities of approximately 70% by cluster
analysis, e.g., strains P1/7 and D282 (Fig. 2, cluster A1, corre-
sponding to Fig. 1A, lanes 21 and 22), as well as isolates
B422/97 and 631/97 (Fig. 2, cluster A2, corresponding to Fig.
1B, lanes 14 and 15). All isolates determined to be closely
related by PFGE with SmaI-digested DNA could be more
clearly differentiated visually in PFGE gels of ApaI-digested
DNA (data not shown). A dendrogram constructed from the
PFGE patterns of ApaI-digested DNA was almost similar to
the dendrogram constructed from the PFGE patterns of SmaI-
digested DNA, except that the degree of differentiation was
higher (data not shown).
Comparison of the clinical backgrounds of isolates with their
assignment to the different clusters revealed that 20 of 48
isolates from pigs with meningitis-septicemia belonged to clus-
ter A1 (Table 1). In contrast, isolates from pigs with pneumo-
nia or from healthy pigs were almost equally distributed among
the different clusters except for cluster A1 (Table 1). The
FIG. 1. Macrorestriction analysis of S. suis isolates by PFGE. (A) PFGE of SmaI-digested DNA of S. suis serotype 9 isolates (lanes 1 to 20 and
23) and, in addition, serotype 2 hemolysin activity-positive control strain P1/7 (lane 21) and serotype 2 MRP- and EF-positive control strain D282
(lane 22). Lane M, size standard (ApaI-digested genomic DNA from S. aureus strain DSM 1104) indicating molecular sizes (in kilobases). (B)
PFGE of ApaI-digested DNA of S. suis serotype 2 isolates (lanes 1 to 24) including the type 2 reference strain (lane 5), MRP- and EF-positive
control strains 4005 (lane 7), T15 (lane 8), and D282 (lane 23), as well as hemolysin activity-positive control strain P1/7 (lane 20). Lane M, size
standard (ApaI-digested genomic DNA from S. aureus, strain DSM 1104) indicating molecular sizes (in kilobases).
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FIG. 2. Dendrogram of similarity among the observed PFGE macrorestriction patterns of SmaI-digested DNAs from 99 S. suis isolates.
Serotypes (ST) and clinical backgrounds (CB) are indicated on the right. Isolates originated either from pigs with typical invasive disease
(meningitis [M], septicemia [S], arthritis [A]), from pigs with pneumonia (P), or from healthy pigs (H). Major clusters are indicated by A1, A2,
B1, and B2. nt, nontypeable.
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phenotypic features of the cluster A1 isolates are described
below.
Serotyping and analysis of potential virulence traits. Results
from serotyping and phenotyping of isolates are summarized in
Tables 2 to 4. The distribution of serotypes within the different
isolates shows that the majority belonged to serotypes 2 (25%)
and 9 (20%), followed by serotypes 3, 7, 1⁄2, 5, 4, and 1 (Table
2). The remaining isolates (indicated as “others” in Table 2)
either belonged to serotype 8, 15, 16, or 25 or were nontype-
able with the antisera used (i.e., antisera to serotypes 1 to 28).
The nontypeable isolates represented 7% of the total number
tested. The most dominant serotypes among all isolates tested,
serotypes 2 and 9, also represented the majority of isolates
from pigs with meningitis-septicemia (44% were serotype 2,
25% were serotype 9), followed by serotype 1 (8% of all men-
ingitis-septicemia isolates) (Table 2). On the other hand, the
serotypes of isolates from pigs with pneumonia showed a
broader distribution, with most of these isolates belonging to
serotype 3, 5, 7, or 9 (Table 2). Interestingly, most isolates from
healthy pigs were nontypeable or belonged to one of the rarely
represented serotypes (both indicated as “others” in Table 2).
Analysis of expression of virulence-associated proteins MRP
and EF (summarized in Table 3) demonstrated that the ma-
jority (67%) of all isolates expressed MRP, either alone or in
combination with expression of EF. None of the isolates ex-
pressed solely EF. Isolates from pigs with meningitis-septice-
mia mostly either expressed MRP alone (52%) or expressed
MRP in combination with EF (29%). Among isolates from pigs
with pneumonia, only one expressed MRP and EF; the remain-
ing isolates expressed either MRP only (52.5%) or neither of
these proteins (45%). All isolates were also tested for hemo-
lysin activity, another potential virulence marker. The results
are shown in Table 4. Isolates were classified as hemolysin
negative, intermediate, or positive with respect to their relative
activity in comparison with the activity of control strain P1/7
(see Materials and Methods). A high proportion of all isolates
were hemolysin negative (50%); only 27% were positive, and
22% were intermediate. This distribution was comparable
among isolates from pigs with meningitis-septicemia and
healthy pigs, whereas a significantly higher proportion (95%)
of isolates from pigs with pneumonia were hemolysin negative
or intermediate. Adherence of streptococci to epithelial cells
was tested since adherence capacity and/or presence of ad-
hesins has been related to the virulence of S. suis (and other
bacteria) in earlier studies (10, 32). Surprisingly, the adherence
of all isolates to two commonly used cell lines, porcine testis
cells and human HEp-2 epithelial cells, was generally very low.
Substantial adherence was observed for only 25% of all isolates
by using porcine cells and only 18% of all isolates by using
HEp-2 cells. The isolates that adhered well to HEp-2 cells were
the same ones that adhered well to porcine cells. There was no
association of adherence capacities with source of isolation
(data not shown).
Taken together, these results showed that certain pheno-
typic features were striking among isolates from pigs with men-
ingitis-septicemia, such as the presence of capsular antigens of
serotypes 2 and 9, expression of MRP and EF, and hemolysin
TABLE 1. Assignment to PFGE clusters among S. suis isolates
from pigs with various clinical backgrounds
PFGE
clustera
No. of
isolates
No. (%) of isolates from:
Pigs with meningitis-
septicemia
Pigs with
pneumonia Healthy pigs
A1 26 20 (42) 5 (12.5) 1 (9)
A2 22 9 (19) 9 (22.5) 4 (36)
B1 32 13 (27) 15 (37.5) 4 (36)
B2 19 6 (12) 11 (27.5) 2 (18)
Total 99 48 (100) 40 (100) 11 (100)
a Isolates were assigned to four different clusters as revealed from cluster
analysis of macrorestriction patterns of SmaI-digested streptococcal DNA.
TABLE 2. Distribution of serotypes among S. suis isolates from
pigs with various clinical backgrounds
Serotype No. ofisolates
No. (%) of isolates from:
Pigs with meningitis-
septicemia
Pigs with
pneumonia
Healthy
pigs
1 5 4 (8) 0 1 (9)
1⁄2 8 2 (4) 5 (10) 1 (9)
2 25 21 (44) 3 (6) 1 (9)
3 9 1 (2) 8 (20) 0
4 6 1 (2) 4 (10) 1 (9)
5 7 2 (4) 5 (12.5) 0
7 8 3 (6) 5 (12.5) 0
9 20 12 (25) 7 (17.5) 1 (9)
Othersa 11 2 (4) 3 (6) 6 (55)
Total 99 48 (100) 40 (100) 11 (100)
a Isolates belonged to serotype 8, 15, 16, or 25 or were nontypeable.
TABLE 3. Expression of MRP and EF among S. suis isolates from
pigs with various clinical backgrounds
MRP/EF expression
statusa
No. of
isolates
No. (%) of isolates from:
Pigs with meningitis-
septicemia
Pigs with
pneumonia
Healthy
pigs
1/1 15 14 (29) 1 (2.5) 0
1/2 52 25 (52) 21 (52.5) 6 (54.5)
2/1 0 0 0 0
2/2 32 9 (19) 18 (45) 5 (45.5)
Total 99 48 (100) 40 (100) 11 (100)
a Isolates expressed MRP and EF (1/1), only MRP (1/2), or none of the two
proteins (2/2); none of the isolates expressed only EF (2/1).
TABLE 4. Hemolysin activities among S. suis isolates from pigs
with various clinical backgrounds
Hemolysin
activitya
No. of
isolates
No. (%) of isolates from:
Pigs with meningitis-
septicemia
Pigs with
pneumonia
Healthy
pigs
1 27 21 (43.7) 2 (5) 4 (36)
6 22 8 (16.6) 13 (32.5) 1 (9)
2 50 19 (39.5) 25 (62.5) 6 (55)
Total 99 48 (100) 40 (100) 11 (100)
a Isolates were grouped as hemolysin positive (1; .80% activity), intermedi-
ate (6; 10 to 80% activity), or negative (2; ,10% activity) in comparison to the
activity of control strain P1/7.
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activity. A more heterogeneous background seemed to exist
within isolates from pigs with pneumonia or healthy pigs.
Relation of individual features of the isolates with clinical
background. We next calculated the probabilities that isolates
with certain features, alone or in combination with each other,
originated from pigs with meningitis-septicemia, which would
indicate a high degree of virulence. A meningitis-septicemia
background was found among 4 of the 5 serotype 1 isolates, 21
of the 25 serotype 2 isolates, and 12 of the 19 serotype 9
isolates (Table 2), indicating a high probability that isolates of
serotypes 2 and 1 and, to a lesser extent, of serotype 9 origi-
nated from pigs with meningitis. On the other hand, most
isolates belonging to serotypes 1⁄2 (five of eight), 3 (eight of
nine), 4 (four of six), 5 (five of seven), or 7 (five of eight) were
from pigs with pneumonia; most isolates designated “others”
originated from healthy animals (Table 2). We also found a
very high probability of the clinical background meningitis-
septicemia among isolates expressing MRP and EF and hemo-
lysin-positive isolates: 14 of the 15 MRP- and EF-positive iso-
lates and 21 of the 27 hemolysin-positive isolates were from
pigs with meningitis-septicemia (Tables 3 and 4). Interestingly,
a high proportion of isolates that lacked hemolysin activity (25
of 50) or that expressed intermediate hemolysin activity (13 of
22) had been isolated from pigs with pneumonia (Table 4).
Moreover, the majority of isolates of PFGE cluster A1 (20 of
26) had a meningitis-septicemia background, and most isolates
of cluster B2 (11 of 19) were from pigs with pneumonia (Table
1). Taken together, these data show that there was a high
probability that isolates exhibiting either the feature serotype 2
or serotype 1 capsular antigen expression, expression of MRP
and EF, strong hemolysin activity, or assignment to PFGE
cluster A1 had a clinical background of meningitis-septicemia.
On the other hand, the features serotype 3, 4, or 5 capsular
antigen expression and a lack of or intermediate hemolysin
activity indicated a high probability of pneumonia as the clin-
ical background.
The probability of the clinical background meningitis-septi-
cemia was even higher when some of the features mentioned
above were found in combination (Fig. 3). We found that of all
serotype 2 isolates, 52% also expressed MRP and EF, 56%
were hemolysin positive, and 56% belonged to cluster A1. All
serotype 2 isolates that were either MRP and EF positive or
hemolysin positive as well as 93% of the serotype 2 isolates
assigned to cluster A1 originated from pigs with meningitis
(Fig. 3A). Of the MRP- and EF-positive isolates, 52% be-
longed to serotype 2, 67% were hemolysin positive, and 67%
belonged to cluster A1, and all isolates with any of these
combinations had been isolated from pigs with meningitis-
septicemia (Fig. 3B). Features of the hemolysin-positive and
cluster A1 isolates in relation to the clinical background men-
ingitis-septicemia are partially included in Fig. 3A and B but
are also shown separately in Fig. 3C and D, respectively.
Taken together, the probability of having a clinical back-
ground of meningitis-septicemia was highest (100%) among
isolates with a combination of serotype 2 with MRP and EF
positivity or hemolysin activity, of MRP and EF positivity with
hemolysin activity or assignment to cluster A1, and of hemo-
lysin activity with assignment to cluster A1. In addition, there
was a striking correlation of serotypes 7 and 9 with a certain
MRP-EF pattern, in that none of these isolates expressed EF.
Furthermore, none of the serotype 7 isolates expressed MRP,
whereas all but one of the serotype 9 isolates expressed MRP,
but most of these expressed a size variant of MRP (37). Only
two (10%) of all serotype 9 isolates were hemolysin positive.
Most serotype 9 isolates were clustered in clusters A2 and B1
(35% each). Only one of the five serotype 1 isolates expressed
MRP and EF (the other four isolates were negative for both),
and all were positive for hemolysin activity. There was no
specific combination of features that was strongly associated
with a background of pneumonia. Furthermore, there was no
association of adherence capacity with a certain other feature.
DISCUSSION
S. suis is a major pathogen in swine and can also infect
humans. The presence of S. suis in pigs, however, is not a good
indicator of disease, since carrier rates of this “early colonizer”
can be up to 100%, with prevalences of disease generally being
not more than 5% (5, 20). This indicates that the level of
virulence varies extremely between strains. Therefore, many
recent studies have been aimed at the identification of pheno-
typic and/or genotypic virulence markers which might be useful
to distinguish virulent from less virulent or avirulent isolates
(23, 26, 29, 35). As with many other pathogens, a single marker
that is sufficient for the identification of all highly virulent
strains has not yet been identified (and probably does not
exist), but there is strong evidence that highly virulent strains
share certain features and might be more related than others
(4, 21, 23, 26). Some of these virulence-associated features
seem to be production of serotype-specific capsular polysac-
charides (25), expression of proteins MRP and EF (35), and
expression of hemolysin activity and suilysin (10, 17, 18). How-
ever, on the basis of the high prevalence of serotype 2 isolates,
most studies have been restricted to serotype 2. Furthermore,
some results might have been overinterpreted with respect to
the terms virulent and avirulent, as recently discussed by
Gottschalk et al. (M. Gottschalk, R. Higgins, and S. Quessy.
Letter, J. Clin. Microbiol. 37:4202–4203, 1999).
The ongoing debate about the relatedness of highly virulent
strains and the poor knowledge about the features of the S. suis
population in Germany prompted us to perform the present
study, in which we characterized a collection of 99 S. suis
isolates including some of the major reference strains. Isolates
were first serotyped to ensure that serotypes other than sero-
type 2 were also represented. The results of serotyping corre-
late well with those of others (7), in that serotypes 2 and 9 are
the dominant serotypes in most European countries except the
United Kingdom, where serotype 1 is most prevalent. Further-
more, we showed that other serotypes such as 1, 1⁄2, 3, 4, 5, and
7 seem to be quite common in the German S. suis population,
which is in agreement with recently published data (36).
Nearly half (48 of 99) of the isolates analyzed for the present
study originated from pigs with typical signs of disease (men-
ingitis, septicemia, arthritis [referred to below as “typical iso-
lates”]); 40 isolates were from pigs with pneumonia. In contrast
to the importance of S. suis as a primary pathogen in pigs with
meningitis, septicemia, or arthritis, it’s causative role in pneu-
monia is not as clear since in many cases S. suis is isolated
together with other lung pathogens such as Pasteurella spp., B.
bronchiseptica, or Mycoplasma spp. (18, 24). Similarly, in our study
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only 16 of 40 S. suis isolates from pigs with pneumonia were
isolated as pure cultures. In agreement with the current knowl-
edge of the pathogenicity of S. suis (14, 18, 24), we therefore
assumed that the isolates from pigs with typical signs (i.e.,
meningitis, etc.) represented the most virulent strains, whereas
isolates from pigs with pneumonia were less invasive and, thus,
less virulent. The remaining 11 of the 99 isolates studied were
from healthy pigs and therefore represented strains from car-
riers. Certainly, it must be considered that the origin of isola-
tion can only give some hints as to an isolate’s capacity to cause
disease but is never proof of an isolate’s virulence.
Taking this into account, we analyzed three S. suis subpopu-
lations (i.e., typical isolates, isolates from pigs with pneumonia,
and isolates from potential carriers) by examining all currently
known putative virulence traits including adherence to epithe-
lial cells. In addition, all isolates were genotyped by macror-
estriction analysis by PFGE, a technique with a high resolution
power which hitherto has not been applied to S. suis. In our
FIG. 3. Comparison of combinations of different features of S. suis isolates with their clinical backgrounds. Additional features of serotype 2
isolates (A), isolates expressing MRP and EF (MRP/EF isolates) (B), hemolysin-positive isolates (Hly isolates) (C), and cluster A1 isolates (A1
isolates) (D) are shown. The leftmost pair of bars in each graph (labeled Total) refers to all isolates expressing the indicated feature; labeling of
the remaining pairs of bars indicates the additional feature found in isolates of the respective group. Each pair of bars shows the proportion of
isolates from pigs with meningitis-septicemia (gray bars) compared to the total proportion of isolates with this combination of features (black bars).
Results are expressed as a percentage of the total number for each group (N), which is indicated in boxes above the respective groups.
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hands, this technique proved to be most suitable for differen-
tiation of single isolates, even those of the same serotype
within an infected herd, and thus should be most valuable in
epidemiological studies with S. suis. Due to the high degree of
sensitivity and the discriminatory power of this technique, how-
ever, isolates that appeared to be identical by visual inspection
could also be found in very closely related instead of identical
branches after cluster analysis. Therefore, it seemed reason-
able to define a cutoff value for identity (i.e., .80%) to exclude
possible overinterpretation of differentiation of two isolates.
The most prominent features among the typical isolates
were the presence of capsular antigens of serotype 2, 9, or 1,
expression of MRP and/or EF, and strong hemolysin activity.
However, these features were found in only about half of this
population; the remaining isolates had more heterogeneous
backgrounds, suggesting that their virulence is attributed to
other characteristics. PFGE and subsequent cluster analysis
confirmed these assumptions, since most of the isolates exhib-
iting one more of these most prominent features were found in
one cluster (cluster A1), whereas the others were more homo-
geneously distributed in the resulting dendrogram. A different
picture was seen in isolates from pigs with pneumonia: sero-
type 2 was rarely found, and in addition to serotype 9, sero-
types 3, 5, and 7 were most prominent. Moreover, only one of
the isolates from pigs with pneumonia expressed both MRP
and EF, and only two isolates from pigs with pneumonia ex-
pressed strong hemolysin activity. This might suggest a lower
capacity of isolates from pigs with pneumonia to express viru-
lence properties, which would correlate well with the assump-
tion that isolates from pigs with pneumonia are less invasive
and virulent than the typical isolates. No significant clustering
of the isolates from pigs with pneumonia was found by cluster
analysis. This indicates that the isolates from pigs with pneu-
monia had more heterogeneous phenotypic and genotypic
backgrounds than typical isolates. Among the isolates from
healthy animals that were potential carriers, the high propor-
tion (55%) of rarely seen serotypes and nontypeable isolates
was most striking, as was the high proportion (36%) of hemo-
lysin-positive isolates. This suggests that S. suis strains from
carriers are more diverse than virulent strains, but this must be
confirmed by analysis of a larger population of isolates.
A surprising finding of the present study was that adherence
to epithelial cells was not correlated at all to the clinical back-
grounds of the isolates, independent of the epithelial cell type
used (human or porcine). This raises the question of the sig-
nificance of adherence as a virulence trait, as suggested by
others (9, 32). An explanation for the poor adherence observed
in our study might be either that adherence is in fact no
virulence trait or that a more specific detection of adhesins is
needed to evaluate the virulence potential of a given strain or
isolate. Concerning the latter, other target cell types (e.g.,
porcine tonsillar epithelial or endothelial cells) and/or different
conditions for bacterial cultivation might have to be tested. In
addition, possible inhibitory effects of encapsulation on adher-
ence might have to be ruled out in future studies, even though
recently published data by Charland et al. (3) did not support
an inhibitory role of the capsule in adherence.
As described above, the phenotypic and genotypic back-
grounds of the isolates from diseased pigs revealed some va-
riety but also confirmed features that were commonly found.
Therefore, we analyzed our data with respect to the probabil-
ities that the commonly found features, alone or in combina-
tion with others, were associated with the clinical background.
The results showed that certain combinations of features such
as the presence of the capsular antigen of serotype 2 and
expression of MRP and EF or the presence of the capsular
antigen of serotype 2 and strong hemolysin activity were highly
correlated with the invasive clinical background meningitis-
septicemia. Furthermore, the probability of such a clinical
background was even higher when isolates expressing one of
those features could be assigned to PFGE cluster A1. In agree-
ment with the findings of others on the specific ribotype pro-
files of virulent strains and isolates (21, 29), our clustering
results strongly support the hypothesis of a relatively conserved
genetic background of highly virulent strains. Together with
our observations on the serotypes and potential virulence traits
of the isolates tested, these data could indicate that certain
highly virulent clones have established themselves successfully
within the European S. suis population.
In conclusion, we have presented evidence that (i) PFGE
analysis is a most valuable tool for epidemiological studies of S.
suis, (ii) several known and yet unknown virulence traits exist
in S. suis which, when combined, can give important hints as to
whether a given isolate is highly virulent, and (iii) highly viru-
lent isolates or strains from pigs with clinical backgrounds of
invasive disease seem to be more related than isolates from
pigs with the less invasive pneumonia or typical isolates from
carriers. This raises the perspective that in the near future it
should be possible to develop strategies for rapid identification
of highly virulent isolates and for monitoring of the epidemi-
ology of S. suis infections.
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